These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8611732)

  • 1. Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation.
    Albi N; Ruggeri L; Aversa F; Merigiola C; Tosti A; Tognellini R; Grossi CE; Martelli MF; Velardi A
    Blood; 1996 May; 87(9):3993-4000. PubMed ID: 8611732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors.
    Vitale C; Pitto A; Benvenuto F; Ponte M; Bellomo R; Frassoni F; Mingari MC; Bacigalupo A; Moretta L
    Hematol J; 2000; 1(2):136-44. PubMed ID: 11920181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
    Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A
    Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
    Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
    Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions.
    Sconocchia G; Lau M; Provenzano M; Rezvani K; Wongsena W; Fujiwara H; Hensel N; Melenhorst J; Li J; Ferrone S; Barrett AJ
    Blood; 2005 Nov; 106(10):3666-72. PubMed ID: 16046526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
    Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
    Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of MHC class I-specific cytolytic activity in IL-2-activated NK1+CD3+ cells and evidence of usage of T and NK cell receptors.
    Takeda K; Dennert G
    Transplantation; 1994 Aug; 58(4):496-504. PubMed ID: 8073519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
    Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L
    J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
    Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.
    Ruggeri L; Capanni M; Casucci M; Volpi I; Tosti A; Perruccio K; Urbani E; Negrin RS; Martelli MF; Velardi A
    Blood; 1999 Jul; 94(1):333-9. PubMed ID: 10381530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA class I-specific natural killer cell receptors on peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation.
    Tanaka J; Tsutsumi Y; Zhang L; Kato N; Mori A; Ohta S; Toyoshima N; Asaka M; Imamura M
    Transplant Proc; 2003 Feb; 35(1):497-8. PubMed ID: 12591503
    [No Abstract]   [Full Text] [Related]  

  • 20. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.